|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
|
|---|---|---|---|---|---|---|
| ASSETS: | ||||||
| Current assets: | ||||||
| Cash | ||||||
| Deferred offering costs associated with public offering | ||||||
| Prepaid expenses | ||||||
| Total current assets | ||||||
| Investments held in Trust Account | ||||||
| Total assets | ||||||
| Current liabilities: | ||||||
| Accrued expenses | ||||||
| Notes payable - related party | ||||||
| Total current liabilities | ||||||
| Liabilities, Noncurrent | ||||||
| Public warrants derivative liability | ||||||
| Advisory fee | ||||||
| Deferred underwriting compensation | ||||||
| Total liabilities | ||||||
| Class A ordinary shares subject to possible redemption, 35,880,000 shares (at redemption value of $10.42 and $10.25 per share at June 30, 2026 and December 31, 2025, respectively) | ||||||
| Shareholders' deficit: | ||||||
| Common stock value | ||||||
| Class A Ordinary Shares | ||||||
| Class B Ordinary Shares | ||||||
| Additional paid-in capital | ||||||
| Accumulated deficit | ||||||
| Total shareholders' deficit | ||||||
| Total liabilities and shareholders' deficit |
Loading...
